5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice.

Abstract:

BACKGROUND:Colorectal peritoneal carcinomatosis (CRPC) is a common form of systemic metastasis of intra-abdominal cancers. Intraperitoneal chemotherapy is a preferable option for colorectal cancer. Here we reported that a new system, 5-FU-loaded hydrogel system, can improve the therapeutic effects of intraperitoneal chemotherapy. METHODS:A biodegradable PEG-PCL-PEG (PECE) triblock copolymer was successfully synthesized. The biodegradable and temperature sensitive hydrogel was developed to load 5-FU. Methylene blue-loaded hydrogel were also developed for visible observation of the drug release. The effects and toxicity of the 5-FU-hydrogel system were evaluated in a murine CRPC model. RESULTS:The hydrogel system is an injectable flowing solution at ambient temperature and forms a non-flowing gel depot at physiological temperature. 5-FU-hydrogel was subsequently injected into abdominal cavity in mice with CT26 cancer cells peritoneal dissemination. The results showed that the hydrogel delivery system prolonged the release of methylene blue; the 5-FU-hydrogel significantly inhibited the peritoneal dissemination and growth of CT26 cells. Furthermore, intraperitoneal administration of the 5-FU-hydrogel was well tolerated and showed less hematologic toxicity. CONCLUSIONS:Our data indicate that the 5-FU-hydrogel system can be considered as a new strategy for peritoneal carcinomatosis, and the hydrogel may provide a potential delivery system to load different chemotherapeutic drugs for peritoneal carcinomatosis of cancers.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Wang Y,Gong C,Yang L,Wu Q,Shi S,Shi H,Qian Z,Wei Y

doi

10.1186/1471-2407-10-402

subject

Has Abstract

pub_date

2010-08-02 00:00:00

pages

402

issn

1471-2407

pii

1471-2407-10-402

journal_volume

10

pub_type

杂志文章
  • Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability.

    abstract:BACKGROUND:Elucidating the molecular mechanisms by which tumors become resistant to Herceptin is critical for the treatment of Her2-overexpressed metastatic breast cancer. METHODS:To further understand Herceptin resistance mechanisms at the molecular level, we used comparative proteome approaches to analyze two human ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-286

    authors: Kang SH,Kang KW,Kim KH,Kwon B,Kim SK,Lee HY,Kong SY,Lee ES,Jang SG,Yoo BC

    更新日期:2008-10-04 00:00:00

  • Study design: two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia.

    abstract:BACKGROUND:Nivestim™ (filgrastim) is a follow-on biologic agent licensed in the EU for the treatment of neutropenia and febrile neutropenia induced by myelosuppressive chemotherapy. Nivestim™ has been studied in phase 2 and 3 clinical trials where its efficacy and safety was found to be similar to its reference product...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-547

    authors: Kamioner D,Fruehauf S,Maloisel F,Cals L,Lepretre S,Berthou C

    更新日期:2013-11-16 00:00:00

  • Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma.

    abstract:BACKGROUND:Reliable methods are needed to identify patients with early-stage cancer or high-grade precancerous lesions in the pancreas. Analysis of pancreatic juice to detect somatic mutations could represent one such approach. Here we investigated the concordance between mutations found in the primary tumor and pancre...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5195-7

    authors: Choi MH,Mejlænder-Andersen E,Manueldas S,El Jellas K,Steine SJ,Tjensvoll K,Sætran HA,Knappskog S,Hoem D,Nordgård O,Hovland R,Molven A

    更新日期:2019-01-05 00:00:00

  • The curious case of Gαs gain-of-function in neoplasia.

    abstract:BACKGROUND:Mutations activating the α subunit of heterotrimeric Gs protein are associated with a number of highly specific pathological molecular phenotypes. One of the best characterized is the McCune Albright syndrome. The disease presents with an increased incidence of neoplasias in specific tissues. MAIN BODY:A si...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4133-z

    authors: Innamorati G,Wilkie TM,Kantheti HS,Valenti MT,Dalle Carbonare L,Giacomello L,Parenti M,Melisi D,Bassi C

    更新日期:2018-03-15 00:00:00

  • Weight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in France.

    abstract:BACKGROUND:Overweight and weight gain throughout adult life have been associated with increased risk of breast cancer after the menopause. However the role of body weight at a young age and of the timing of weight gain over the lifetime in postmenopausal breast cancer is not well documented. METHODS:We conducted a pop...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2793-0

    authors: Cordina-Duverger E,Truong T,Anger A,Sanchez M,Arveux P,Kerbrat P,Guénel P

    更新日期:2016-09-29 00:00:00

  • Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas.

    abstract:BACKGROUND:Esophageal squamous cell carcinoma (ESCC) shows a 5-year survival rate below 10%, demonstrating the urgency in improving its treatment. Alterations in epidermal growth factor receptors are closely related to malignancy transformation in a number of tumors and recent successful targeted therapies have been di...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-569

    authors: Gonzaga IM,Soares-Lima SC,de Santos PT,Blanco TC,de Reis BS,Quintella DC,de Oliveira IM,de Faria PA,Kruel CD,Andreollo NA,de Simão TA,Pinto LF

    更新日期:2012-12-04 00:00:00

  • COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.

    abstract:BACKGROUND:Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature cells that accumulates in tumour-bearing hosts. These cells are induced by tumour-derived factors (e.g. prostaglandins) and have a critical role in immune suppression. MDSC suppress T and NK cell function via increased express...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-464

    authors: Veltman JD,Lambers ME,van Nimwegen M,Hendriks RW,Hoogsteden HC,Aerts JG,Hegmans JP

    更新日期:2010-08-30 00:00:00

  • VEGFR2 regulates endothelial differentiation of colon cancer cells.

    abstract:BACKGROUND:Recent studies suggested that cancer stem-like cells contribute to tumor vasculogenesis by differentiating into endothelial cells. However, such process is governed by still undefined mechanism. METHODS:At varying differentiation levels, three representative colon cancer cells were cultured in endothelial-i...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3578-9

    authors: Liu Z,Qi L,Li Y,Zhao X,Sun B

    更新日期:2017-08-30 00:00:00

  • JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells.

    abstract:BACKGROUND:Nitric oxide (NO) and its oxidative reaction products have been repeatedly shown to block steroid receptor function via nitrosation of zinc finger structures in the DNA-binding domain (DBD). In consequence NO-donors could be of special interest for the treatment of deregulated androgen receptor(AR)-signaling...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-130

    authors: Laschak M,Spindler KD,Schrader AJ,Hessenauer A,Streicher W,Schrader M,Cronauer MV

    更新日期:2012-03-30 00:00:00

  • Age and stage at diagnosis: a hospital series of 11 women with intellectual disability and breast carcinoma.

    abstract:BACKGROUND:Breast cancer has been poorly studied in women with intellectual disability (ID), which makes designing a policy for screening the nearly 70 million women with ID in the world difficult. As no data is available in the literature, we evaluated breast cancer at diagnosis in women with ID. METHODS:Women with I...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-150

    authors: Satgé D,Sauleau EA,Jacot W,Raffi F,Azéma B,Bouyat JC,El Hage Assaf N

    更新日期:2014-03-04 00:00:00

  • An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.

    abstract:BACKGROUND:The radiopharmaceutical (131)I-meta-iodobenzylguanidine ((131)I-MIBG) is an effective treatment for neuroblastoma. However, maximal therapeutic benefit from (131)I-MIBG is likely to be obtained by its combination with chemotherapy. We previously reported enhanced antitumour efficacy of (131)I-MIBG by inhibit...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2656-8

    authors: Nile DL,Rae C,Hyndman IJ,Gaze MN,Mairs RJ

    更新日期:2016-08-11 00:00:00

  • Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.

    abstract:BACKGROUND:Although adjuvant chemotherapy with S-1 after curative gastrectomy has been performed as a standard treatment for Stage II and III gastric cancer (GC) in Japan, patients with Stage III GC still have a high incidence of recurrence and a poor prognostic outcome. The aim of this study was to investigate risk fa...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4052-z

    authors: Nishibeppu K,Komatsu S,Ichikawa D,Imamura T,Kosuga T,Okamoto K,Konishi H,Shiozaki A,Fujiwara H,Otsuji E

    更新日期:2018-01-30 00:00:00

  • Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma.

    abstract:BACKGROUND:The standard therapy regimen of conventional osteosarcoma includes neoadjuvant chemotherapy followed by surgical resection and postoperative chemotherapy. The percentage of necrotic tissue following induction chemotherapy is assessed by using the Huvos grading system, which classifies patients as "poor respo...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-606

    authors: Salas S,Jiguet-Jiglaire C,Campion L,Bartoli C,Frassineti F,Deville JL,Maues De Paula A,Forest F,Jézéquel P,Gentet JC,Bouvier C

    更新日期:2014-08-20 00:00:00

  • Application of ultrasound artificial intelligence in the differential diagnosis between benign and malignant breast lesions of BI-RADS 4A.

    abstract:BACKGROUND:The classification of Breast Imaging Reporting and Data System 4A (BI-RADS 4A) lesions is mostly based on the personal experience of doctors and lacks specific and clear classification standards. The development of artificial intelligence (AI) provides a new method for BI-RADS categorisation. We analysed the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07413-z

    authors: Niu S,Huang J,Li J,Liu X,Wang D,Zhang R,Wang Y,Shen H,Qi M,Xiao Y,Guan M,Liu H,Li D,Liu F,Wang X,Xiong Y,Gao S,Wang X,Zhu J

    更新日期:2020-10-02 00:00:00

  • Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.

    abstract:BACKGROUND:Ovarian cancer (OV) is one of the most common malignant tumors of gynecology oncology. The lack of effective early diagnosis methods and treatment strategies result in a low five-year survival rate. Also, immunotherapy plays an important auxiliary role in the treatment of advanced OV patient, so it is of gre...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07695-3

    authors: Yan S,Fang J,Chen Y,Xie Y,Zhang S,Zhu X,Fang F

    更新日期:2020-12-07 00:00:00

  • Population attributable risks of oral cavity cancer to behavioral and medical risk factors in France: results of a large population-based case-control study, the ICARE study.

    abstract:BACKGROUND:Population attributable risks (PARs) are useful tool to estimate the burden of risk factors in cancer incidence. Few studies estimated the PARs of oral cavity cancer to tobacco smoking alone, alcohol drinking alone and their joint consumption but none performed analysis stratified by subsite, gender or age. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-015-1841-5

    authors: Radoï L,Menvielle G,Cyr D,Lapôtre-Ledoux B,Stücker I,Luce D,ICARE Study Group.

    更新日期:2015-10-31 00:00:00

  • Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer.

    abstract:BACKGROUND:Colorectal cancer (CRC) ranks the third among the most common malignancies globally. It is well known that microRNAs (miRNAs) play vital roles in destabilizing mRNAs and repressing their translations in this disease. However, the mechanism of miRNA-induced mRNA cleavage remains to be investigated. METHOD:In...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06717-4

    authors: Zhou F,Tang D,Xu Y,He H,Wu Y,Lin L,Dong J,Tan W,Dai Y

    更新日期:2020-03-23 00:00:00

  • The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy.

    abstract:BACKGROUND:The prognostic value of rectal invasion is still unclear in stage IVA cervical cancer. The objective of this study is to evaluate patient outcome and prognostic factors in stage IVA cervical cancer treated with radiation therapy. METHODS:A retrospective review of the medical records of patients treated with...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2268-3

    authors: Wakatsuki M,Kato S,Kiyohara H,Ohno T,Karasawa K,Tamaki T,Ando K,Shiba S,Kamada T,Nakano T

    更新日期:2016-03-23 00:00:00

  • Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study.

    abstract:BACKGROUND:There are three main therapeutic strategies, namely expectant management (dilation and curettage only), prophylactic chemotherapy and prophylactic total hysterectomy for treating older women with complete hydatidiform mole (CHM). However, the scientific community has so far, not unanimously accepted the abov...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3749-8

    authors: Zhao P,Chen Q,Lu W

    更新日期:2017-11-09 00:00:00

  • Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.

    abstract:OBJECTIVE:Crizotinib can target against mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK), which has been considered as a multi-targeted tyrosine kinase inhibitor (TKI). The objective of this study was to explore the efficacy of crizotinib in advanced non-small-cell lung cancer (NSCLC) with c...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5078-y

    authors: Chen RL,Zhao J,Zhang XC,Lou NN,Chen HJ,Yang X,Su J,Xie Z,Zhou Q,Tu HY,Zhong WZ,Yan HH,Guo WB,Wu YL,Yang JJ

    更新日期:2018-11-26 00:00:00

  • Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. SFRP1 (the secreted frizzled-related protein 1), a putative tumor suppressor gene mapped onto chromosome 8p12-p11.1, the frequent loss of heterozygosity (LOH) region in human HCC, encodes a Wingless-type (Wnt) signaling antagonist...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-126

    authors: Huang J,Zhang YL,Teng XM,Lin Y,Zheng DL,Yang PY,Han ZG

    更新日期:2007-07-12 00:00:00

  • Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.

    abstract:BACKGROUND:Previous data from our laboratory has indicated that there is a functional link between the beta-adrenergic receptor signaling pathway and the G-protein inwardly rectifying potassium channel (GIRK1) in human breast cancer cell lines. We wanted to determine if GIRK channels were expressed in lung cancers and ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-104

    authors: Plummer HK 3rd,Dhar MS,Cekanova M,Schuller HM

    更新日期:2005-08-18 00:00:00

  • 18F- FDG PET/CT helps differentiate autoimmune pancreatitis from pancreatic cancer.

    abstract:BACKGROUND:18F-FDG PET/CT could satisfactorily show pancreatic and extra-pancreatic lesions in AIP, which can be mistaken for pancreatic cancer (PC). This study aimed to identify 18F-FDG PET/CT findings that might differentiate AIP from PC. METHODS:FDG-PET/CT findings of 26 AIP and 40 PC patients were reviewed. Pancre...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3665-y

    authors: Zhang J,Jia G,Zuo C,Jia N,Wang H

    更新日期:2017-10-23 00:00:00

  • The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer.

    abstract:BACKGROUND:Breast cancer is the most common malignancy in women world-wide. Triple negative breast cancer (TNBC) is a highly aggressive subtype that lacks expression of hormone receptors for estrogen, progesterone and human epidermal growth factor 2; and is associated with a high propensity for metastatic spread. Sever...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-253

    authors: Avery-Kiejda KA,Braye SG,Forbes JF,Scott RJ

    更新日期:2014-04-11 00:00:00

  • Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies.

    abstract:BACKGROUND:The development of non-small cell lung carcinoma proceeds through a series of well-defined pathological steps before the appearance of invasive lung carcinoma. The molecular changes that correspond with pathology changes are not well defined and identification of the molecular events may provide clues on the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-155

    authors: Tichelaar JW,Zhang Y,leRiche JC,Biddinger PW,Lam S,Anderson MW

    更新日期:2005-12-06 00:00:00

  • Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach.

    abstract:BACKGROUND:The high complication rates of surgically implanted port catheter systems (SIPCS) represents a major drawback in the treatment of isolated liver neoplasms by hepatic arterial infusion (HAI) of chemotherapy. Interventionally implanted port catheter systems (IIPCS) have evolved into a promising alternative tha...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-69

    authors: Hildebrandt B,Pech M,Nicolaou A,Langrehr JM,Kurcz J,Bartels B,Miersch A,Felix R,Neuhaus P,Riess H,Dörken B,Ricke J

    更新日期:2007-04-24 00:00:00

  • Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions.

    abstract:BACKGROUND:To determine, in a meta-analysis, the diagnostic performance of quantitative diffusion-weighted (DW) MR imaging in patients with breast lesions. METHODS:English and Chinese studies published prior to June 2009 to assess the diagnostic performance of quantitative DWI in patients with breast lesions were revi...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/1471-2407-10-693

    authors: Chen X,Li WL,Zhang YL,Wu Q,Guo YM,Bai ZL

    更新日期:2010-12-29 00:00:00

  • Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study.

    abstract:BACKGROUND:The 'common variant, common disease' model predicts that a significant component of hereditary breast cancer unexplained by pathogenic variants in moderate or high-penetrance genes is due to the cumulative effect of common risk variants in DNA (polygenic risk). Assessing a woman's breast cancer risk by testi...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/s12885-017-3485-0

    authors: Yanes T,Meiser B,Young MA,Kaur R,Mitchell G,Barlow-Stewart K,Roscioli T,Halliday J,James P

    更新日期:2017-07-18 00:00:00

  • Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer.

    abstract:BACKGROUND:The aim of this study was to evaluate epigenetic status of cyclin A1 in human papillomavirus-associated cervical cancer. Y. Tokumaru et al., Cancer Res 64, 5982-7 (Sep 1, 2004)demonstrated in head and neck squamous-cell cancer an inverse correlation between cyclin A1 promoter hypermethylation and TP53 mutati...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-55

    authors: Kitkumthorn N,Yanatatsanajit P,Kiatpongsan S,Phokaew C,Triratanachat S,Trivijitsilp P,Termrungruanglert W,Tresukosol D,Niruthisard S,Mutirangura A

    更新日期:2006-03-08 00:00:00

  • Replicase-based plasmid DNA shows anti-tumor activity.

    abstract:BACKGROUND:Double stranded RNA (dsRNA) has multiple anti-tumor mechanisms. Over the past several decades, there have been numerous attempts to utilize synthetic dsRNA to control tumor growth in animal models and clinical trials. Recently, it became clear that intracellular dsRNA is more effective than extracellular dsR...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-110

    authors: Rodriguez BL,Yu Z,Chung WG,Weiss R,Cui Z

    更新日期:2011-03-28 00:00:00